GOSS: Gossamer Bio, Inc. Common Stock Company Profile & Statistics

Gossamer Bio, Inc. Common Stock Profile

About

Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company's product pipeline includes GB001, GB002, GB004, GB1275, Autoimmune program and Oncology program which are in clinical stage. Gossamer Bio Inc. is based in San Diego, California.

Info & Links

CEO

Faheem Hasnain

Headquarters

3115 Merryfield Row, Suite 120
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

145

Gossamer Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

685.55M

Enterprise Value

857.25M

Enterprise Value/EBITDA(ttm)

-5.58

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.72

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-41.12%

Profit Margin(ttm)

-345.18%

Return on Equity(ttm)

-128.98%

Return on Invested Capital(ttm)

-71.13%

Return on Assets(ttm)

-15.52%

Income Statement

Revenue(ttm)

40.24M

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

40.24M

EBITDA(ttm)³

-153.57M

Net Income Available to Common(ttm)

-138.74M

Diluted EPS(ttm)

-0.23

Share Statistics

Beta (5Y Monthly)

1.95

52-Week Change

228.79%

S&P 500 52-Week Change

17.14%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

227.38M

Dividend Yield

0.00%

Float⁴

212.07M

% Held by Insiders

6.70%

% Held by Institutions

81.23%

Balance Sheet

Total Cash(mrq)

212.92M

Total Cash Per Share(mrq)

0.94

Total Debt(mrq)

198.01M

Total Debt/Equity(mrq)

-429.46%

Current Ratio(mrq)

4.40%

Quick Ratio(mrq)

5.71%

Book Value Per Share(mrq)

-0.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-86.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GOSS

Gossamer Bio, Inc. Common Stock